Protocol No.: BB2121-EAP-001

Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release
Principal Investigator
Veltri, Lauren
Phase
NA
Age Group
Adult
Applicable Disease Site
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Crystal Peck, RN
BMT Coordinator
Phone: +1 304-598-4500

View on ClinicalTrials.gov